Charles Chapron

ORCID: 0000-0003-2578-3163 · 356 papers in corpus
rct 2023
Drugs in R&D ·doi:10.1007/s40268-023-00427-5

INTRODUCTION: BAY1128688 is a selective inhibitor of aldo-keto reductase family 1 member C3 (AKR1C3), an enzyme implicated in the pathology of endometriosis and other disorders. In vivo animal studies suggested a potential therapeutic appli…

2023
·doi:10.1016/j.jeud.2023.100031

Consequences of the shift from the use of non-invasive testing for diagnosis to screening purposes • As the high-throughput screening and sequencing become increasingly faster and affordable, that there will be a swell of commercial non-inv…

observational 2023
Journal of gynecology obstetrics and human reproduction ·doi:10.1016/j.jogoh.2023.102708

OBJECTIVE: To investigate the medical journey and the quality of life of French endometriosis-affected women, from the onset of the symptoms to the therapeutic management. STUDY DESIGN: Between January 15th 2020 and February 3rd 2020, a pr…

observational 2023
Reproductive sciences (Thousand Oaks, Calif.) ·doi:10.1007/s43032-023-01173-4

In order to inform patients undergoing ART regarding their chances for motherhood, it seems useful to describe "freeze all" outcomes according to the different potential indications. The goal of this study was to examine the impact of a "fr…

observational 2023
Reproductive BioMedicine Online ·doi:10.1016/j.rbmo.2023.02.008

RESEARCH QUESTION: Is there a change in magnetic resonance imaging (MRI) criteria of diffuse and focal phenotypes of adenomyosis before and after pregnancy? DESIGN: A retrospective, monocentric, observational study in a single academic ter…

observational 2023
Reproductive BioMedicine Online ·doi:10.1016/j.rbmo.2023.05.008

RESEARCH QUESTION: What are the reproductive outcomes and the prognostic factors of live birth rates in patients with endometriosis referred to oocyte donation after multiple IVF failures? DESIGN: Observational cohort study including all w…

observational 2023
·doi:10.1093/humrep/dead093.687

Abstract Study question What are the reproductive outcomes and the prognostic factors of live birth rates in endometriosis patients referred to oocyte donation after multiple in vitro fertilization(IVF)-failures? Summary answer In this spec…

2023
·doi:10.1016/b978-2-294-78134-6.00006-1
observational 2023
Fertility and sterility ·doi:10.1016/j.fertnstert.2023.11.039

OBJECTIVE: To compare assisted reproductive technologies (ARTs) outcomes between fresh vs. freeze-all strategies in infertile women affected by adenomyosis. DESIGN: A single-center observational study. SETTINGS: University hospital-based …

review 2023
Journal of gynecology obstetrics and human reproduction ·doi:10.1016/j.jogoh.2023.102664

The French National College of Obstetricians and Gynecologists (CNGOF) published guidelines for managing endometriosis-associated pain in 2018. Given the development of new pharmacological therapies and a review that was published in 2021, …

observational 2023
·doi:10.1016/j.jeud.2023.100050

To determine whether recurrent endometriomas are associated with multiple deep infiltrating endometriosis (DIE) lesions. This was an observational, cross-sectional, cohort study of 611 consecutive symptomatic women with endometrioma who und…

observational 2022
Fertility and sterility ·doi:10.1016/j.fertnstert.2022.12.039

OBJECTIVE: To evaluate the prevalence on magnetic resonance imaging (MRI) of ovarian endometrioma (OMA) and deep infiltrating endometriosis (DIE) in adolescents presenting with severe dysmenorrhea. DESIGN: Prospective study. SETTING: Clin…

other 2022
EClinicalMedicine ·doi:10.1016/j.eclinm.2021.101263

BACKGROUND: The time between symptoms onset and endometriosis diagnosis is usually long. The negative impacts of delayed endometriosis diagnosis can affect patients and health outcomes. METHODS: We conducted a case-control study using clin…

observational 2022
JAMA network open ·doi:10.1001/jamanetworkopen.2021.47788

IMPORTANCE: Endometriosis is an inflammatory disease with a heterogeneous presentation that affects women of childbearing age. Given the limitations of previous retrospective studies, it is still unclear whether endometriosis has adverse im…

review 2022
Healthcare (Basel, Switzerland) ·doi:10.3390/healthcare10122515

This work provides consensus guidance regarding clinical diagnosis and early medical management of endometriosis within Asia. Clinicians with expertise in endometriosis critically evaluated available evidence on clinical diagnosis and early…

guideline 2022
Human Reproduction ·doi:10.1093/humrep/deac166

STUDY QUESTION: What outcomes should be reported in all studies investigating uterus-sparing interventions for treating uterine adenomyosis? SUMMARY ANSWER: We identified 24 specific and 26 generic core outcomes in nine domains. WHAT IS K…

other 2022
Reproduction & fertility ·doi:10.1530/raf-22-0041

IN VITRO: culturing of endometrial cells obtained from the uterine mucosa or ectopic sites is used to study molecular and cellular signalling relevant to physiologic and pathologic reproductive conditions. However, the lack of consensus on …

observational 2022
Reproductive BioMedicine Online ·doi:10.1016/j.rbmo.2022.08.097

RESEARCH QUESTION: Does endometrioma size affect the number of oocytes retrieved after ovarian stimulation in women with endometriosis-related infertility undergoing IVF/intracytoplasmic sperm injection (ICSI)? DESIGN: Cohort study of infe…

lab-animal 2022
·doi:10.1093/humrep/deac107.350

Abstract Study question Are there any fertility disorders and related local and/or systemic immune changes during the early implantation period in a mouse model of adenomyosis? Summary answer An increase in fertility disorders was observed …

observational 2022
Human Reproduction ·doi:10.1093/humrep/deac083

STUDY QUESTION: What is the impact of adenomyosis on the live birth rate (LBR) in women affected by endometriosis women undergoing ART? SUMMARY ANSWER: For women undergoing ART, the presence of adenomyosis at MRI, especially T2 high-signal…

other 2022
Biomedicines ·doi:10.3390/biomedicines10092065

Objective: To identify circulating miRNAs associated with ovarian endometriosis (OMA), and to analyze candidate genes targeted by these miRNAs. Methods: Putative regulating miRNAs were identified through an original bioinformatics approach.…

review 2022
Fertility and sterility ·doi:10.1016/j.fertnstert.2022.08.011

Abnormal uterine bleeding (AUB) is a clinical entity which can lead to iron deficiency anemia. Classification according to the acronym PALM-COEIN (polyp, adenomyosis, leiomyoma, malignancy, and hyperplasia; coagulopathy, ovulatory dysfuncti…

review 2021
Journal of gynecology obstetrics and human reproduction ·doi:10.1016/j.jogoh.2021.102228

Adenomyosis is a common gynecologic disease characterized by invasion of endometrial glands and stroma within the myometrium. Clinically, it can result in abnormal uterine bleeding, pelvic pain, and infertility. Adenomyosis has historically…

observational 2021
Fertility and sterility ·doi:10.1016/j.fertnstert.2021.02.031

OBJECTIVE: To determine whether the adenomyosis phenotype affects the proton nuclear magnetic resonance (1H-NMR)-based serum metabolic profile of patients. DESIGN: Cohort study. SETTING: University hospital-based research center. PATIENT…

review 2021
Gynecologie, obstetrique, fertilite & senologie ·doi:10.1016/j.gofs.2021.10.005

Adenomyosis is a chronic benign uterine disease characterized by the presence of endometrial glands and stroma within the myometrium. It is a heterogeneous disease, presenting various clinical forms, depending on the location of the ectopic…